ASCENT-07: A phase 3, randomized, open-label study of sacituzumab govitecan versus treatment of physician's choice in patients with HR+/HER2- inoperable, locally advanced, or metastatic breast cancer post-endocrine therapy
Sacituzumab Govitecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: ASCENT-07: A phase 3, randomized, open-label study of sacituzumab govitecan versus treatment of physician's choice in patients with HR+/HER2- inoperable, locally advanced, or metastatic breast cancer post-endocrine therapy ### Output: Sacituzumab Govitecan